Skip to main content

Advertisement

SpringerLink
Log in

Intracranial melanotic schwannomas: a rare variant with unusual adherent features

  • Clinical Study
  • Published:
Journal of Neuro-Oncology Aims and scope Submit manuscript

Abstract

Intracranial melanotic schwannomas (IMSch) are extremely rare nerve sheath tumors with features of Schwann cells that produce melanin. After a thorough review of the available literature since 1967, we report not only the 20th case of IMSch but a comprehensive modern-era analysis of radiographic and histological key-points to be considered when diagnosing and treating patients with this rare known entity. This is the case of a 43 years-old woman who presented with severe headaches 9 years ago (2008). At that time, MRI of the brain showed a 1.5 × 1.4 cm lesion at the level of the left cerebellar peduncle without any evidence of edema, mass effect or hydrocephalus. Given that the patient was neurologically intact, a conservative management with serial MRIs was recommended. Patient stopped following up due to the absence of symptoms. Over the course of the past year, patient noted mild left sided hearing loss and facial weakness, as well as some balance instability that progressed over the last 3 months. Given the presentation and progression of these signs and symptoms, a new MRI was performed in which considerable growth of the lesion was identified, measuring 2.5 × 2.8 × 2.6 cm with mass effect on the pons and the inferior fourth ventricle. She underwent a far lateral approach without a C1 hemilaminectomy for the resection of this lesion. Final pathology was consistent with a non-psammomatous melanotic schwannoma (NPMS) with areas of necrosis. Besides this case, only two other cases of IMSch with findings of necrosis have been reported in the literature, all of them reporting a subtotal resection. Evaluation of all previously reported cases of IMSch shows a male prevalence with a 1.6:1 male to female ratio. IMSch is radiographically T2 hypointense and can be differentiated from Schwannomas that are classically T2 hyperintense. In this case, only a subtotal resection was feasible due to the tumor’s overwhelming inherent attachment to vital structures such as cranial nerves (CN), brainstem, and vasculature. While MSch is considered histologically benign, several factors including localization, surrounding structures, the rate of growth, tumor volume resection and histological necrosis should be considered in determining prognosis and further adjuvant treatment planning.

Graphical Abstract

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Torres-Mora J, Dry S, Li X, Binder S, Amin M, Folpe AL (2014) Malignant melanotic schwannian tumor: a clinicopathologic, immunohistochemical, and gene expression profiling study of 40 cases, with a proposal for the reclassification of “melanotic schwannoma”. Am J Surg Pathol 38(1):94–105. doi: 10.1097/PAS.0b013e3182a0a150

    Article  PubMed  Google Scholar 

  2. Millar WG (1932) A malignant melanotic tumour of ganglion cells arising from a thoracic sympathetic ganglion. J Pathol 35(3):351–357

    Article  Google Scholar 

  3. Arvanitis LD (2010) Melanotic schwannoma: a case with strong CD34 expression, with histogenetic implications. Pathol Res Pract 206(10):716–719. doi:10.1016/j.prp.2010.02.011

    Article  PubMed  Google Scholar 

  4. Burns DK, Silva FG, Forde KA, Mount PM, Clark HB (1983) Primary melanocytic schwannoma of the stomach. Evidence of dual melanocytic and schwannian differentiation in an extra-axial site in a patient without neurofibromatosis. Cancer 52(8):1432–1441

    Article  CAS  PubMed  Google Scholar 

  5. Höllinger P, Godoy N, Sturzenegger M (1999) Magnetic resonance imaging findings in isolated spinal psammomatous melanotic schwannoma. J Neurol 246(11):1100–1102

    Article  PubMed  Google Scholar 

  6. Marton E, Feletti A, Orvieto E, Longatti P (2007) Dumbbell-shaped C-2 psammomatous melanotic malignant schwannoma. Case report and review of the literature. J Neurosurg Spine 6(6):591–599. doi:10.3171/spi.2007.6.6.14

    Article  PubMed  Google Scholar 

  7. Myers JL, Bernreuter W, Dunham W (1990) Melanotic schwannoma. Clinicopathologic, immunohistochemical, and ultrastructural features of a rare primary bone tumor. Am J Clin Pathol 93(3):424–429

    Article  CAS  PubMed  Google Scholar 

  8. Shields JA, Font RL, Eagle RC Jr, Shields CL, Gass JD (1994) Melanotic schwannoma of the choroid. Immunohistochemistry and electron microscopic observations. Ophthalmology 101(5):843–849

    Article  CAS  PubMed  Google Scholar 

  9. Spina A, Gagliardi F, Boari N, Terreni MR, Mortini P (2015) Intracranial melanotic schwannomas. J Neurol Surg A 76(5):399–406. doi:10.1055/s-0034-1393926

    Article  Google Scholar 

  10. Er U, Kazanci A, Eyriparmak T, Yigitkanli K, Senveli E (2007) Melanotic schwannoma. J Clin Neurosci 14(7):676–678

    Article  PubMed  Google Scholar 

  11. Beck DW, Menezes AH (1987) Lesions in Meckel’s cave: variable presentation and pathology. J Neurosurg 67(5):684–689

    Article  CAS  PubMed  Google Scholar 

  12. Buhl R, Barth H, Hugo HH, Mautner VF, Mehdorn HM (2004) Intracranial and spinal melanotic schwannoma in the same patient. J Neurooncol 68(3):249–254

    Article  PubMed  Google Scholar 

  13. Carney JA (1990) Psammomatous melanotic schwannoma: a distinctive, heritable tumor with special associations, including cardiac myxoma and the Cushing syndrome. Am J Surg Pathol 14(3):206–222

    Article  CAS  PubMed  Google Scholar 

  14. Carrasco CA, Rojas-Salazar D, Chiorino R, Venega JC, Wohllk N (2006) Melanotic nonpsammomatous trigeminal schwannoma as the first manifestation of Carney complex: case report. Neurosurgery 59(6):E1334

    Article  PubMed  Google Scholar 

  15. Dastur DK, Sinh G, Pandya S (1967) Melanotic tumor of the acoustic nerve: case report. J Neurosurg 27(2):166–170

    Article  Google Scholar 

  16. Díaz Beveridge R, Richart Aznar P, Núñez Lozano C, Chirivella Casanova M, Corbellas Aparicio M, Montalar Salcedo J (2010) Orbital and myocardial metastases of a primary pulmonary melanotic schwannoma. Clin Transl Oncol 12(7):509–511

    Article  PubMed  Google Scholar 

  17. Ditz C, Brunswig K, Meyer C, Reusche E, Nowak G, Tronnier V (2011) Intracranial melanotic schwannoma: a case report of recurrence with extra-and intradural manifestation two decades after initial diagnosis and treatment. Cent Eur Neurosurg 72(04):211–215

    Article  CAS  PubMed  Google Scholar 

  18. Earls JP, Robles HA, McAdams H, Rao K (1994) General case of the day. Malignant melanotic schwannoma of the eighth cranial nerve. Radiographics 14(6):1425–1427

    Article  CAS  PubMed  Google Scholar 

  19. Jensen O, Bretlau P (1990) Melanotic schwannoma of the orbit. Apmis 98(7–12):713–723

    Article  CAS  PubMed  Google Scholar 

  20. Mey K, Buchwald C, Daugaard S, Prause J (2006) Sinonasal schwannoma—a clinicopathological analysis of five rare cases. Rhinology 44(1):46

    CAS  PubMed  Google Scholar 

  21. Miller R, Sarikaya H, Sos A (1986) Melanotic schwannoma of the acoustic nerve. Arch Pathol Lab Med 110(2):153–154

    CAS  PubMed  Google Scholar 

  22. Quencer RM, Stokes NA, Wolfe D, Page LK (1979) Melanotic nerve sheath tumor of the gasserian ganglion and trigeminal nerve. Am J Roentgenol 133(1):142–144

    Article  CAS  Google Scholar 

  23. Ranjan A, Chacko G, Chandi S (1995) Intracerebellar melanotic schwannoma: a case report. Br J Neurosurg 9(5):687–690

    Article  CAS  PubMed  Google Scholar 

  24. Saint-Blancard P, Goasguen O, Kossowski M, Dulou R (2008) A rare primary tumor of the cerebellopontine angle: melanotic schwannoma, a pigmented tumor with unpredictable prognosis. La Revue de medecine interne 29(7):587–590

    Article  CAS  PubMed  Google Scholar 

  25. Scheithauer BW, Erdogan S, Rodriguez FJ, Burger PC, Woodruff JM, Kros JM, Gokden M, Spinner RJ (2009) Malignant peripheral nerve sheath tumors of cranial nerves and intracranial contents: a clinicopathologic study of 17 cases. Am J Surg Pathol 33(3):325–338

    Article  PubMed  Google Scholar 

  26. Zhang HY, Yang GH, Chen HJ, Wei B, Ke Q, Guo H, Ye L, Bu H, Yang K, Zhang YH (2005) Clinicopathological, immunohistochemical, and ultrastructural study of 13 cases of melanotic schwannoma. Chin Med J 118(17):1451–1461

    PubMed  Google Scholar 

  27. Culhaci N, Dikicioglu E, Meteoglu I, Boylu S (2003) Multiple melanotic schwannoma. Ann Diagn Pathol 7(4):254–258

    Article  PubMed  Google Scholar 

  28. Atlas SW, Grossman RI, Gomori JM, Guerry D, Hackney DB, Goldberg HI, Zimmerman RA, Bilaniuk LT (1987) MR imaging of intracranial metastatic melanoma. J Comput Assist Tomogr 11(4):577–582

    Article  CAS  PubMed  Google Scholar 

  29. Tawk RG, Tan D, Mechtler L, Fenstermaker RA (2005) Melanotic schwannoma with drop metastases to the caudal spine and high expression of CD117 (c-kit). J Neurooncol 71(2):151–156. doi:10.1007/s11060-004-9301-0

    Article  PubMed  Google Scholar 

  30. Vallat-Decouvelaere AV, Wassef M, Lot G, Catala M, Moussalam M, Caruel N, Mikol J (1999) Spinal melanotic schwannoma: a tumour with poor prognosis. Histopathology 35(6):558–566

    Article  CAS  PubMed  Google Scholar 

  31. Benet A, Rincon-Torroella J, Vivas-Buitrago T, Quiñones-Hinojosa A (2016) Far lateral approach. In: Quinones-Hinojosa A (ed) Video Atlas of neurosurgery, contemporary tumor and skull base surgery. Elsevier, New York, pp 137–146

    Google Scholar 

  32. Font RL, Truong LD (1984) Melanotic schwannoma of soft tissues. Electron-microscopic observations and review of literature. Am J Surg Pathol 8(2):129–138

    Article  CAS  PubMed  Google Scholar 

  33. Nitzan E, Pfaltzgraff ER, Labosky PA, Kalcheim C (2013) Neural crest and Schwann cell progenitor-derived melanocytes are two spatially segregated populations similarly regulated by Foxd3. Proc Natl Acad Sci USA 110(31):12709–12714

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  34. Thomas AJ, Erickson CA (2009) FOXD3 regulates the lineage switch between neural crest-derived glial cells and pigment cells by repressing MITF through a non-canonical mechanism. Development 136(11):1849–1858. doi:10.1242/dev.031989

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  35. Napoli I, Noon LA, Ribeiro S, Kerai AP, Parrinello S, Rosenberg LH, Collins MJ, Harrisingh MC, White IJ, Woodhoo A, Lloyd AC (2012) A central role for the ERK-signaling pathway in controlling schwann cell plasticity and peripheral nerve regeneration in vivo. Neuron 73(4):729–742. doi:10.1016/j.neuron.2011.11.031

    Article  CAS  PubMed  Google Scholar 

  36. Adameyko I, Lallemend F, Aquino JB, Pereira JA, Topilko P, Müller T, Fritz N, Beljajeva A, Mochii M, Liste I, Usoskin D, Suter U, Birchmeier C, Ernfors P (2009) Schwann cell precursors from nerve innervation are a cellular origin of melanocytes in skin. Cell 139(2):366–379. doi:10.1016/j.cell.2009.07.049

    Article  CAS  PubMed  Google Scholar 

  37. Rizvi TA, Huang Y, Sidani A, Atit R, Largaespada DA, Boissy RE, Ratner N (2002) A novel cytokine pathway suppresses glial cell melanogenesis after injury to adult nerve. J Neurosci 22(22):9831–9840

    CAS  PubMed  PubMed Central  Google Scholar 

  38. Hoover JM, Bledsoe JM, Giannini C, Krauss WE (2012) Intramedullary melanotic schwannoma. Rare Tumors 4(1):e3. doi:10.4081/rt.2012.e3

    Article  PubMed  PubMed Central  Google Scholar 

  39. Merat R, Szalay-Quinodoz I, Laffitte E, Kaya G (2015) Psammomatous melanotic schwannoma: a challenging histological diagnosis. Dermatopathology 2(3):67–70. doi:10.1159/000442708

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Author information

Author notes

  1. D. Mahato and T. Vivas-Buitrago have contributed equally.

Authors and Affiliations

  1. Department of Neurological Surgery, Mayo Clinic, 4500 San Pablo Rd S, Jacksonville, FL, 32224, USA

    D. Mahato, T. Vivas-Buitrago, K. Gassie & A. Quiñones-Hinojosa

  2. Department of Neuro-Pathology, Mayo Clinic, Jacksonville, FL, USA

    M. Jentoft

  3. Department of Neurological Surgery, University of Florida, Jacksonville, FL, USA

    D. Tavanaiepour

Authors
  1. D. Mahato
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. T. Vivas-Buitrago
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. K. Gassie
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. M. Jentoft
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. D. Tavanaiepour
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. A. Quiñones-Hinojosa
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to A. Quiñones-Hinojosa.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Mahato, D., Vivas-Buitrago, T., Gassie, K. et al. Intracranial melanotic schwannomas: a rare variant with unusual adherent features. J Neurooncol 136, 299–306 (2018). https://doi.org/10.1007/s11060-017-2653-z

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11060-017-2653-z

Keywords

Search

Navigation